A NEW ROBUST ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF RIBOCICLIB AND LETROZOLE IN SOLID DOSAGE FORM (TABLET)

Authors

  • BHAGYALATA SATAPATHY Avanthi Institute of Pharmaceutical Science, Visakhapatnam, India.
  • CHAITANYA BANGARI Avanthi Institute of Pharmaceutical Science, Visakhapatnam, India.

DOI:

https://doi.org/10.22159/ajpcr.2021.v14i11.41511

Keywords:

RP-HPLC, Ribociclib, Letrozole, Method validation and simultaneous estimation

Abstract

Objective: The objective of the study was to develop a new robust, sensitive, precise, accurate RP-HPLC analytical method and validate for simultaneous estimation of ribociclib and letrozole in solid dosage form (tablet).

Methods: The chromatographic separation was carried out on Waters, symmetry C18 (150 mm×4.6 mm with 3.5 μm), mobile phase used was a mixture of buffer and acetonitrile in the ratio of 80:20, with flow rate of 1ml/min and injection volume of 10 μL for the assay. The detection was done using PDA at 260 nm, with run time of 5 min. The retention time for the drugs ribociclib and letrozole was detected to be 2.648 min and 3.151 min, respectively. The method was validated according to ICH guidelines.

Results: The linearity of letrozole and ribociclib was observed to be in the range of 0.50–7.50 and 40.01–600.15, Correlation coefficient (r2) 0.999 and 0.9983, respectively. Accuracy for ribociclib and letrozole is carried out by repeatable concentrations of 50%, 100%, and 150. Validation factors of robustness and ruggedness were detected to be in limits.

Conclusion: The developed method was simple, rapid, and consistent; it can be used for the simultaneous estimation of ribociclib and letrozole tablet dosage form in routine analysis.

Downloads

Download data is not yet available.

References

Kala A, Patel YT, Davis A, Stewart CF. Development and validation of LC-MS/MS methods for the measurement of ribociclib, a CDK4/6 inhibitor, in mouse plasma and Ringer’s solution and its application to a cerebral microdialysis study. J Chromatogr B Analyt Technol Biomed Life Sci 2017;1057:110-7. DOI: https://doi.org/10.1016/j.jchromb.2017.05.002

Kaplan C, Ünal S. A Validated Method without Derivatization for the Determination of Letrozole by High Performance Liquid Chromatography-Fluorimetric Method for Pharmaceutical Preparation. Turkey: Istanbul University Press; 2018. p. 38-42. DOI: https://doi.org/10.5152/IstanbulJPharm.2018.397094

Mondal N, Pal TK, Ghosal SK. Development and validation of RP-HPLC method to determine letrozole in different pharmaceutical formulations and its application to studies of drug release from nanoparticles. Acta Pol Pharm 2009;66:11-7.

Sreelakshmi M, Sasidhar RL, Raviteja B. Simultaneous estimation of ribociclib and palbociclib in bulk samples by reverse phase high performance liquid chromatography. Pharm Anal Qual Assur 2019; ???:73-9.

Bao X, Wu J, Sanai N, Li J. Determination of total and unbound ribociclib in human plasma and brain tumor tissues using liquid chromatography coupled with tandem mass spectrometry. J Pharm Biomed Anal 2019;166:197-204. DOI: https://doi.org/10.1016/j.jpba.2019.01.017

Dange Y, Bhinge S, Salunkhe V. Optimization and validation of RP-HPLC method for simultaneous estimation of palbociclib and letrozole. Toxicol Mech Methods 2018;28:187-94. DOI: https://doi.org/10.1080/15376516.2017.1388458

Published

07-11-2021

How to Cite

SATAPATHY, B., and C. BANGARI. “A NEW ROBUST ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF RIBOCICLIB AND LETROZOLE IN SOLID DOSAGE FORM (TABLET)”. Asian Journal of Pharmaceutical and Clinical Research, vol. 14, no. 11, Nov. 2021, pp. 129-34, doi:10.22159/ajpcr.2021.v14i11.41511.

Issue

Section

Original Article(s)